Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-24

FDA Approved: EXEMESTANE — Supplemental Application (Florida Pharmaceutical Products, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Exemestane submitted by Florida Pharmaceutical Products, LLC. Exemestane is an aromatase inhibitor used in the t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exemestane (Exemestane)

Snippet

SUPPL AP for EXEMESTANE (EXEMESTANE)